Product Information
LIDOCAINE HCL 1% 200 MG/20 ML is a generic product labeled by Eugia US LLC, priced at $0.0700 per ML under NDC 55150025224. Its NADAC has been published 63 times since Jul 23, 2025.
FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Eugia US LLCNDC
55150025224
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207182FDA Approved
10/30/2017
TE Code
AP
On Market Since
10/30/2017
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% 200 MG/20 ML has been published 63 times since Jul 23, 2025, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0700 per ML |
|---|---|
| All-time high | $0.0769 (Oct 15, 2025) |
| All-time low | $0.0681 (Jul 22, 2026) |
| 52-week high | $0.0769 |
| 52-week low | $0.0681 |
| Median price | $0.0732 |
| Average price | $0.0733 |
| Largest weekly change | -4.1% (Jun 17, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% 200 MG/20 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% 200 MG/20 ML, manufactured by Eugia US LLC, is $0.0700 per ML (NDC 55150025224), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 1% 200 MG/20 ML changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% 200 MG/20 ML has declined 7.2%. It has been tracked across 63 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% 200 MG/20 ML?
Since Jul 23, 2025, the NADAC for LIDOCAINE HCL 1% 200 MG/20 ML has ranged from a low of $0.0681 (Jul 22, 2026) to a high of $0.0769 (Oct 15, 2025), with a median of $0.0732 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% 200 MG/20 ML?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0681 per ML — about 3% below LIDOCAINE HCL 1% 200 MG/20 ML.
Who manufactures LIDOCAINE HCL 1% 200 MG/20 ML?
LIDOCAINE HCL 1% 200 MG/20 ML (NDC 55150025224) is labeled by Eugia US LLC, and CMS classifies it as a generic product.